237 related articles for article (PubMed ID: 36606559)
1. Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome
Jeffreys LN; Ardrey A; Hafiz TA; Dyer LA; Warman AJ; Mosallam N; Nixon GL; Fisher NE; Hong WD; Leung SC; Aljayyoussi G; Bibby J; Almeida DV; Converse PJ; Fotouhi N; Berry NG; Nuermberger EL; Upton AM; O'Neill PM; Ward SA; Biagini GA
ACS Infect Dis; 2023 Feb; 9(2):221-238. PubMed ID: 36606559
[No Abstract] [Full Text] [Related]
2. The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd.
Lu P; Asseri AH; Kremer M; Maaskant J; Ummels R; Lill H; Bald D
Sci Rep; 2018 Feb; 8(1):2625. PubMed ID: 29422632
[TBL] [Abstract][Full Text] [Related]
3. Exploiting the synthetic lethality between terminal respiratory oxidases to kill
Kalia NP; Hasenoehrl EJ; Ab Rahman NB; Koh VH; Ang MLT; Sajorda DR; Hards K; Grüber G; Alonso S; Cook GM; Berney M; Pethe K
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7426-7431. PubMed ID: 28652330
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy.
Zhou Y; Shao M; Wang W; Cheung CY; Wu Y; Yu H; Hu X; Cook GM; Gong H; Lu X
Eur J Med Chem; 2023 Jan; 245(Pt 1):114896. PubMed ID: 36370551
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis.
Lee BS; Hards K; Engelhart CA; Hasenoehrl EJ; Kalia NP; Mackenzie JS; Sviriaeva E; Chong SMS; Manimekalai MSS; Koh VH; Chan J; Xu J; Alonso S; Miller MJ; Steyn AJC; Grüber G; Schnappinger D; Berney M; Cook GM; Moraski GC; Pethe K
EMBO Mol Med; 2021 Jan; 13(1):e13207. PubMed ID: 33283973
[TBL] [Abstract][Full Text] [Related]
6. An amiloride derivative is active against the F
Hards K; Cheung CY; Waller N; Adolph C; Keighley L; Tee ZS; Harold LK; Menorca A; Bujaroski RS; Buckley BJ; Tyndall JDA; McNeil MB; Rhee KY; Opel-Reading HK; Krause K; Preiss L; Langer JD; Meier T; Hasenoehrl EJ; Berney M; Kelso MJ; Cook GM
Commun Biol; 2022 Feb; 5(1):166. PubMed ID: 35210534
[TBL] [Abstract][Full Text] [Related]
7. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
[TBL] [Abstract][Full Text] [Related]
8. Novel targets and inhibitors of the
Harikishore A; Mathiyazakan V; Pethe K; Grüber G
Expert Opin Drug Discov; 2023; 18(8):917-927. PubMed ID: 37332221
[TBL] [Abstract][Full Text] [Related]
9. Response of
Chauhan P; van der Meulen SA; Simões Caetano JM; Goojani HG; Botman D; van Spanning R; Lill H; Bald D
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142240
[TBL] [Abstract][Full Text] [Related]
10. Targeting the cytochrome oxidases for drug development in mycobacteria.
Lee BS; Sviriaeva E; Pethe K
Prog Biophys Mol Biol; 2020 May; 152():45-54. PubMed ID: 32081616
[TBL] [Abstract][Full Text] [Related]
11. Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc
Kalia NP; Shi Lee B; Ab Rahman NB; Moraski GC; Miller MJ; Pethe K
Sci Rep; 2019 Jun; 9(1):8608. PubMed ID: 31197236
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of (Quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives as inhibitors of Mycobacterium tuberculosis bd oxidase.
Kumar A; Kumari N; Bhattacherjee S; Venugopal U; Parwez S; Siddiqi MI; Krishnan MY; Panda G
Eur J Med Chem; 2022 Nov; 242():114639. PubMed ID: 35973312
[TBL] [Abstract][Full Text] [Related]
13. Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?
Bajeli S; Baid N; Kaur M; Pawar GP; Chaudhari VD; Kumar A
Front Cell Infect Microbiol; 2020; 10():589318. PubMed ID: 33330134
[TBL] [Abstract][Full Text] [Related]
14. Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation.
Zeng S; Soetaert K; Ravon F; Vandeput M; Bald D; Kauffmann JM; Mathys V; Wattiez R; Fontaine V
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642937
[TBL] [Abstract][Full Text] [Related]
15. Targeting the menaquinol binding loop of mycobacterial cytochrome bd oxidase.
Harikishore A; Chong SSM; Ragunathan P; Bates RW; Grüber G
Mol Divers; 2021 Feb; 25(1):517-524. PubMed ID: 31939065
[TBL] [Abstract][Full Text] [Related]
16. Structure guided generation of thieno[3,2-
Hopfner SM; Lee BS; Kalia NP; Miller MJ; Pethe K; Moraski GC
RSC Med Chem; 2021 Jan; 12(1):73-77. PubMed ID: 34046599
[TBL] [Abstract][Full Text] [Related]
17. A Mycobacterium tuberculosis cytochrome bd oxidase mutant is hypersensitive to bedaquiline.
Berney M; Hartman TE; Jacobs WR
mBio; 2014 Jul; 5(4):e01275-14. PubMed ID: 25028424
[TBL] [Abstract][Full Text] [Related]
18. Structure of
Zhou S; Wang W; Zhou X; Zhang Y; Lai Y; Tang Y; Xu J; Li D; Lin J; Yang X; Ran T; Chen H; Guddat LW; Wang Q; Gao Y; Rao Z; Gong H
Elife; 2021 Nov; 10():. PubMed ID: 34819223
[TBL] [Abstract][Full Text] [Related]
19. The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress.
Lu P; Heineke MH; Koul A; Andries K; Cook GM; Lill H; van Spanning R; Bald D
Sci Rep; 2015 May; 5():10333. PubMed ID: 26015371
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome bd in Mycobacterium tuberculosis: A respiratory chain protein involved in the defense against antibacterials.
Mascolo L; Bald D
Prog Biophys Mol Biol; 2020 May; 152():55-63. PubMed ID: 31738981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
